Disagree
Home Hilma Biocare Hilma Biocare
Semaglutide
Semaglutide - Hilma Biocare

Semaglutide - Hilma Biocare

Brand:
Category:
Substance:
Package:
2 mg
Price:
0
See options
Product Overview
As a GLP-1 receptor agonist, Semaglutide enhances insulin secretion, lowers glucagon, and supports weight loss by influencing appetite regulation. It reduces inflammation across key tissues, including the liver, heart, and brain, showing promise for treating NASH, cardiovascular disease, and neurodegenerative disorders. By decreasing cytokines, oxidative stress, and CRP levels, Semaglutide extends beyond diabetes care to address chronic inflammation, metabolic dysfunction, and cognitive decline associated with aging and obesity.
References:

Mehdi, S.F., Pusapati, S., Anwar, M.S., Lohana, D., Kumar, P., Nandula, S.A., Nawaz, F.K., Tracey, K., Yang, H., LeRoith, D., Brownstein, M.J. and Roth, J., 2023. Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent. Frontiers in Immunology

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Semaglutide by Hilma Biocare, consult with your doctor or healthcare professional.

Explore More Products
FAQ
Is Glucagon-like peptide-1 (GLP-1) active in the central nervous system?
Yes, Glucagon-like peptide-1 (GLP-1) acts in the brain to regulate appetite and inflammation.
References:

Mehdi, S.F., Pusapati, S., Anwar, M.S., Lohana, D., Kumar, P., Nandula, S.A., Nawaz, F.K., Tracey, K., Yang, H., LeRoith, D., Brownstein, M.J. and Roth, J., 2023. Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent. Frontiers in Immunology

How does Glucagon-like peptide-1 (GLP-1) behave in Parkinson’s models?
Glucagon-like peptide-1 (GLP-1) analogs reduce neuroinflammation and oxidative stress in Parkinson’s models.
References:

Mehdi, S.F., Pusapati, S., Anwar, M.S., Lohana, D., Kumar, P., Nandula, S.A., Nawaz, F.K., Tracey, K., Yang, H., LeRoith, D., Brownstein, M.J. and Roth, J., 2023. Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent. Frontiers in Immunology

Can Glucagon-like peptide-1 (GLP-1) protect against cytokine damage?
Yes, Glucagon-like peptide-1 (GLP-1) lowers cytokine activity in multiple tissues, including the heart and gut.
References:

Mehdi, S.F., Pusapati, S., Anwar, M.S., Lohana, D., Kumar, P., Nandula, S.A., Nawaz, F.K., Tracey, K., Yang, H., LeRoith, D., Brownstein, M.J. and Roth, J., 2023. Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent. Frontiers in Immunology